20 th World Congress on Vascular Dementia and Neurodegenerative DIseases

The conference will focus on the intricate relationship between neurovascular dysfunction and cognitive decline, exploring how vascular issues like small vessel disease and hypoperfusion contribute to vascular dementia and overlap with Alzheimer's. It will cover stroke and post-stroke dementia, the impact of hypertension and diabetes, white matter lesions, the roles of inflammation and the blood-brain barrier, AI in early diagnosis, mixed dementia pathologies, lifestyle modifications, drug development, and emerging therapies. Additionally, it will delve into biomarkers for Alzheimer's and Parkinson's, molecular mechanisms of neurodegeneration (tauopathies, synucleinopathies), mitochondrial dysfunction, the gut-brain axis, gene therapy, protein misfolding, neuroimaging advances, targeting neurovascular dysfunction in neurodegenerative diseases, personalized medicine, and stem cell/regenerative medicine for future therapies.